期刊文献+

MMP-9和TIMP-1在胃癌组织中的表达失衡及其与ZHX2的相关性 被引量:10

Correlation between MMP-9/TIMP-1 imbalance and ZHX2 expression in gastric carcinoma
下载PDF
导出
摘要 目的:探讨胃癌中MMP-9和TIMP-1蛋白表达与ZHX2蛋白表达的关系,并分析其与胃癌患者临床病理特征的相关性及其临床意义.方法:应用免疫组织化学Envision二步法检测62例胃癌组织及癌旁正常胃组织中MMP-9、TIMP-1及ZHX2蛋白的表达.用SPSS13.0统计软件分析MMP-9和TIMP-1蛋白表达与ZHX2蛋白表达的相关性,并分析其与患者的临床病理特征的关系.结果:MMP-9蛋白在62例胃癌组织及癌旁正常胃组织中阳性表达率分别为66.13%(41/62)和29.03%(18/62)(P<0.01),TIMP-1蛋白在胃癌组织及癌旁正常胃组织中阳性表达率分别为41.94%(26/62)和74.19%(46/62)(P<0.01).MMP-9蛋白表达在ZHX2阳性和阴性表达组中的阳性率分别为:84.44%(38/45)和17.65%(3/17)(P<0.05),与患者的年龄、性别、肿瘤大小、发生部位、大体类型、分化程度、淋巴结转移、远处转移、TNM分期均无关(P>0.05),而与肿瘤的浸润深度有关(P<0.05);TIMP-1蛋白表达在ZHX2阳性和阴性组中阳性率分别为:28.89%(13/45)和76.47%(13/17)(P<0.05),与患者的年龄、性别、肿瘤大小、发生部位、大体类型、分化程度、浸润深度、淋巴结转移、远处转移、TNM分期均无关(P>0.05).结论:MMP-9高表达可以作为评估胃癌恶性生物学行为及预后的指标,MMP-9/TIMP-1表达失衡与ZHX2表达相关,MMP-9和TIMP-1可为临床选择化疗药物提供参考依据. AIM: To detect the expression of matrix metal- loproteinase 9 (MMP-9), tissue inhibitor of me- talloproteinase-1 (TIMP-1) and ZHX2 in gastric carcinoma and to analyze their association with pathological features. METHODS: Immunohistochemistry was used to examine the expression of MMP-9, TIMP-1, and ZHX2 proteins in 62 cases of gastric carcinoma and matched tumor-adjacent tissue specimens. The correlation of MMP-9, TIMP-1 and ZHX2 pro- tein expression with clinicopathological character- istics of gastric carcinoma was then analyzed. RESULTS: The positive rate of MMP-9 expres-sion was significantly higher (66.13% vs 29.03%, P 〈 0.01), and that of TIMP-1 was significantly lower (41.94% vs 74.19%, P 〈 0.01) in gastric carcinoma than in tumor-adjacent tissue. The positive rate of MMP-9 expression was signifi- cantly higher in the ZHX2-positive group than in the ZHX2-negative group (84.44% vs 17.65%, P 〈 0.05). MMP-9 expression was not associated with age, gender, tumor size, tumor location, general type, tumor differentiation, lymph node metastasis, distant metastasis, or TNM stage, but was significantly associated with depth of invasion (P 〈 0.05). The positive rate of TIMP-1 expression was significantly lower in the ZHX2- positive group than in the ZHX2-negative group (28.89% vs 76.49%, P 〈 0.05). TIMP-1 expression was not associated with age, gender, tumor size, tumor location, general type, tumor differentia- tion, depth of invasion, lymph node metastasis, distant metastasis, or TNM stage.CONCLUSION: Detection of MMP-9 protein ex- pression may be used to assess the malignant biological behavior and prognosis of gastric carcinoma. MMP-9/TIMP-1 imbalance may be related to the expression of ZHX2 in gastric car- cinoma,
出处 《世界华人消化杂志》 CAS 北大核心 2012年第20期1832-1837,共6页 World Chinese Journal of Digestology
基金 广西青年科学基金资助项目 No.0728057~~
关键词 基质金属蛋白酶9 基质金属蛋白酶组织抑制剂 ZHX2 胃癌组织 临床病理特征 免疫组织化学 Matrix metalloproteinase 9 Tissueinhibitor of metalloproteinase-I ZHX2 Gastric car-cinoma Clinicopathological features Immunohisto-chemistry
  • 相关文献

参考文献3

二级参考文献41

共引文献24

同被引文献91

  • 1Ming-Zhe Weng,Peng-Yuan Zhuang,Zhen-Yu Hei,Pei-Yi Lin,Zhi-Sheng Chen,Ying-Bin Liu,Zhi-Wei Quan,Zhao-Hui Tang.ZBTB20 is involved in liver regeneration after partial hepatectomy in mouse[J].Hepatobiliary & Pancreatic Diseases International,2014,13(1):48-54. 被引量:5
  • 2董绍安,赵景岚,林乐胜.食管鳞状细胞癌组织MMP-2、9与TIMP-1表达及意义[J].青岛大学医学院学报,2007,43(2):105-107. 被引量:10
  • 3王萍,杨金凤,张庆,承泽农,于东红.基质金属蛋白酶-9基因在胃癌及癌旁组织中的表达及意义[J].中国基层医药,2007,14(4):559-561. 被引量:5
  • 4Joyce E. Matrix metalloproteinases ,angiogenesis,and cancer[J]. Clin Cancer Res,2003,9:551.
  • 5王阿曼,蔡欣,周涛,等.MMP-2、VEGF、CD105和Ki-67在小细胞肺癌中的表达及预后相关性研究[J].临床肿瘤学建志,2012,17(1I):988-993.
  • 6Crew KD, Neugut A. Epidemiology of upper gastrointestinal malignancies[J. Semin Oncol,2004,31:450 464.
  • 7Pohn H, Welch HG. The role of overdiagnosis and reclassifi cation in the marked increase of esophageal adenocarcinoma in- cidence[J. Natl Cancer Inst, 2005,97:142 146.
  • 8Parkin MD, Bray F, Ferlay J,et al. Global cancer statistics 2002[J. CA Cancer J Clin, 2005,55:74-108.
  • 9EI-Shahat M, Lofty M, Fahmy L, et al. Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 pro tein expression in esophageal cancer[J. Egypt Natl Cancer Inst, 2004. 16:224 230.
  • 10Vallbohmer D, Lenz HJ. Predictive and prognostic molecular markers in outcome oi" esophageal cancer[J. Dis Esophagus, 2006,19:425-432.

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部